MapLight Therapeutics, Inc
Price
FilingsNewest: 424B3, ProspectusSep 23 →Insiders4 insiders bought $109.4M in 6 open-market buys. 8 insiders sold $17.5M, 63 of 93 sales on a 10b5-1 plan.→HoldersNovo Holdings A/S 8.1%FCPM Iii Services B.V. 7.1%Goldman Sachs 4.3%→Financing →PeersClosest companies: ATAI, AARD, APRE→
From the filings
Figures
- Net income
- −$229.8Mlast 12 months
- Operating cash flow
- −$163.8Mlast 12 months
- Cash and equivalents
- $71.6Mat the last balance sheet
- Shares outstanding
- 45.4M shareson issue